IDH1 and glioma: Nearly all IDH1-mutant gliomas contain methylated O-6-methylguanine-DNA methyltransferase (MGMT) genes, which sensitize tumors to temozolomide (TMZ) therapy (Hegi et al., 2005; Mulholland et al., 2012).